Charles Cherington Insider Profile

11 Followers
Charles Cherington, Ten Percent Owner at Eterna Therapeutics, holds 16.63M shares in Eterna Therapeutics (Ticker: ERNA), holds 7.37M shares in Comera Life Sciences Holdings (Ticker: CMRA). Most recently, Charles Cherington Bought ― shares of Eterna Therapeutics on Nov 05, 2024 for an estimated value of 1.37M.
tipranks
Charles Cherington

Charles Cherington
Eterna Therapeutics (ERNA)
Ten Percent Owner

Ranked #95,867 out of 99,335 Corporate Insiders

Profitable Transactions

10%
1 out of 10 Profitable Transactions

Average Return

-56.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$19M
99.61%
0.39%
A breakdown of Charles Cherington's holdings

Insider Roles

Eterna Therapeutics
(ERNA)
Ten Percent Owner
Comera Life Sciences Holdings
(CMRA)
Ten Percent Owner
Roles that Charles Cherington holds in companies

Most Profitable Insider Trade

Stock:
Eterna Therapeutics
(ERNA)
Rating:Informative Sell
Date:Jun 21, 2021 - Jun 21, 2022
Return:+97.00%
The most profitable trade made by Charles Cherington

Charles Cherington's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Eterna Therapeutics
Nov 05, 2024
Ten Percent Owner
Informative Buy
1.37M
$18.79M
Comera Life Sciences Holdings
Sep 11, 2023
Ten Percent Owner
Informative Buy
1.05M
$73.68K
List of latest transactions for each holding click on a transaction to see Charles Cherington's performance on stock

Charles Cherington insider profile FAQ

What is the percentage of profitable transactions made by Charles Cherington?
The percentage of profitable transactions made by Charles Cherington is 10%.
    What is the average return per transaction made by Charles Cherington?
    The average return per transaction made by Charles Cherington is -56.90%.
      What stocks does Charles Cherington hold?
      Charles Cherington holds: ERNA, CMRA stocks.
        What was Charles Cherington’s latest transaction?
        Charles Cherington latest transaction was an Informative Buy of $1.37M.
          What was Charles Cherington's most profitable transaction?
          Charles Cherington’s most profitable transaction was an Informative Sell of ERNA stock on June 21, 2021. The return on the trade was 97.00%.
            What is Charles Cherington's role in Eterna Therapeutics?
            Charles Cherington's role in Eterna Therapeutics is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.